Literature DB >> 26386588

Rituximab treatment for refractory steroid-resistant nephrotic syndrome.

Koichi Kamei1, Kenji Ishikura2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26386588     DOI： 10.1007/s00467-015-3205-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin.

Authors:  Hiroshi Kaito; Koichi Kamei; Eriko Kikuchi; Masao Ogura; Kentaro Matsuoka; Michio Nagata; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2009-12-22       Impact factor: 3.714

2.  Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome.

Authors:  Koichi Kamei; Mari Okada; Mai Sato; Takuya Fujimaru; Masao Ogura; Makiko Nakayama; Hiroshi Kaito; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2014-02-06       Impact factor: 3.651

3.  Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome.

Authors:  Clare E Counsilman; Cornelia M Jol-van der Zijde; Jasper Stevens; Karlien Cransberg; Robbert G M Bredius; Ram N Sukhai
Journal:  Pediatr Nephrol       Date:  2015-06-09       Impact factor: 3.714
  3 in total
  1 in total

Review 1.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.

Authors:  Agnes Trautmann; Marina Vivarelli; Susan Samuel; Debbie Gipson; Aditi Sinha; Franz Schaefer; Ng Kar Hui; Olivia Boyer; Moin A Saleem; Luciana Feltran; Janina Müller-Deile; Jan Ulrich Becker; Francisco Cano; Hong Xu; Yam Ngo Lim; William Smoyer; Ifeoma Anochie; Koichi Nakanishi; Elisabeth Hodson; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2020-05-07       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.